Blood vessel segmentation in en-face OCTA images: a frequency based method
Anna Breger, Felix Goldbach, Bianca S. Gerendas, Ursula, Schmidt-Erfurth, Martin Ehler

TL;DR
This paper introduces a novel frequency-based segmentation method using Gabor filter banks for analyzing retinal blood vessels in OCTA images, demonstrating good qualitative and quantitative results on in-house data.
Contribution
The paper presents a new segmentation approach based on frequency representations, specifically Gabor filters, for improved retinal vessel analysis in OCTA images.
Findings
Segmentation outcomes received very good expert visual feedback.
Quantitative vessel density values closely matched device-provided values.
Manual annotations showed high agreement with the proposed method.
Abstract
Optical coherence tomography angiography (OCTA) is a novel noninvasive imaging modality for visualization of retinal blood flow in the human retina. Using specific OCTA imaging biomarkers for the identification of pathologies, automated image segmentations of the blood vessels can improve subsequent analysis and diagnosis. We present a novel segmentation method for vessel density identification based on frequency representations of the image, in particular, using so-called Gabor filter banks. The algorithm is evaluated qualitatively and quantitatively on an OCTA image in-house data set from eyes acquired by a Cirrus HD-OCT device. Qualitatively, the segmentation outcomes received very good visual evaluation feedback by experts. Quantitatively, we compared the resulting vessel density values with automated in-built values provided by the device. The results underline the visual…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal Imaging and Analysis · Optical Coherence Tomography Applications · Retinal Diseases and Treatments
